PL366012A1 - Kompozycja i sposób oznaczania glikozydazy - Google Patents
Kompozycja i sposób oznaczania glikozydazyInfo
- Publication number
- PL366012A1 PL366012A1 PL01366012A PL36601201A PL366012A1 PL 366012 A1 PL366012 A1 PL 366012A1 PL 01366012 A PL01366012 A PL 01366012A PL 36601201 A PL36601201 A PL 36601201A PL 366012 A1 PL366012 A1 PL 366012A1
- Authority
- PL
- Poland
- Prior art keywords
- glycosidase
- determining
- composition
- determining glycosidase
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23307500P | 2000-09-15 | 2000-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366012A1 true PL366012A1 (pl) | 2005-01-24 |
Family
ID=22875789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01366012A PL366012A1 (pl) | 2000-09-15 | 2001-09-14 | Kompozycja i sposób oznaczania glikozydazy |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6656699B2 (pl) |
| EP (1) | EP1356083A2 (pl) |
| JP (1) | JP2004529606A (pl) |
| AU (1) | AU2001294563A1 (pl) |
| CA (1) | CA2426517A1 (pl) |
| IL (1) | IL154904A0 (pl) |
| MX (1) | MXPA03002243A (pl) |
| NO (1) | NO20031177L (pl) |
| PL (1) | PL366012A1 (pl) |
| WO (1) | WO2002023197A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL366012A1 (pl) * | 2000-09-15 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Kompozycja i sposób oznaczania glikozydazy |
| EP1385990A4 (en) * | 2001-05-09 | 2004-09-22 | Insight Biopharmaceuticals Ltd | METHODS AND MATERIALS USING HEPARANASE AS A DIAGNOSTIC MARKER FOR HEMOSTATIC DISORDERS |
| WO2003011119A2 (en) * | 2001-07-31 | 2003-02-13 | Reddy Us Therapeutics, Inc. | Methods and compositions for diagnosis and treatment of vascular conditions |
| WO2005040163A1 (en) | 2003-10-28 | 2005-05-06 | Dr. Reddy's Laboratories Ltd | Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| WO2009075774A2 (en) * | 2007-12-05 | 2009-06-18 | Massachusetts Institute Of Technology | Glycosaminoglycan-coated particles and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859581A (en) | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| EP0532695A1 (en) * | 1990-05-31 | 1993-03-24 | Board Of Regents, The University Of Texas System | Immunochemical localization of heparanase in mouse and human melanomas |
| AU7368994A (en) * | 1993-07-29 | 1995-02-28 | Upjohn Company, The | Use of heparanase to identify and isolate anti-heparanase compound |
| TW565614B (en) | 1996-07-18 | 2003-12-11 | Univ Australian | Detection of mammalian heparanase activity and purification of mammalian heparanase |
| US5968822A (en) | 1997-09-02 | 1999-10-19 | Pecker; Iris | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| US6177545B1 (en) | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| US6190875B1 (en) | 1997-09-02 | 2001-02-20 | Insight Strategy & Marketing Ltd. | Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| EP1032656A4 (en) | 1997-10-28 | 2002-10-29 | Univ Australian | ISOLATED NUCLEIC ACID MOLECULES, WHICH CODES FOR ENDOGLUCURONIDASE FROM MAMMALS, AND THEIR USE |
| GB9802725D0 (en) | 1998-02-09 | 1998-04-08 | Ciba Geigy Ag | Organic compounds |
| EP1060252A2 (en) | 1998-02-24 | 2000-12-20 | PHARMACIA & UPJOHN COMPANY | Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
| EP1157118A4 (en) | 1999-03-01 | 2002-07-17 | Insight Strategy & Marketing | POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS |
| GB9913415D0 (en) | 1999-06-10 | 1999-08-11 | Central Manchester Healthcare | Heparanase assay |
| PL366012A1 (pl) * | 2000-09-15 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Kompozycja i sposób oznaczania glikozydazy |
-
2001
- 2001-09-14 PL PL01366012A patent/PL366012A1/pl unknown
- 2001-09-14 IL IL15490401A patent/IL154904A0/xx unknown
- 2001-09-14 JP JP2002527793A patent/JP2004529606A/ja active Pending
- 2001-09-14 US US09/952,648 patent/US6656699B2/en not_active Expired - Fee Related
- 2001-09-14 CA CA002426517A patent/CA2426517A1/en not_active Abandoned
- 2001-09-14 AU AU2001294563A patent/AU2001294563A1/en not_active Abandoned
- 2001-09-14 WO PCT/US2001/028862 patent/WO2002023197A2/en not_active Ceased
- 2001-09-14 EP EP01975215A patent/EP1356083A2/en not_active Withdrawn
- 2001-09-14 MX MXPA03002243A patent/MXPA03002243A/es unknown
-
2003
- 2003-03-14 NO NO20031177A patent/NO20031177L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002023197A3 (en) | 2003-07-24 |
| JP2004529606A (ja) | 2004-09-30 |
| WO2002023197A2 (en) | 2002-03-21 |
| MXPA03002243A (es) | 2004-12-03 |
| US6656699B2 (en) | 2003-12-02 |
| IL154904A0 (en) | 2003-10-31 |
| NO20031177D0 (no) | 2003-03-14 |
| US20020064806A1 (en) | 2002-05-30 |
| NO20031177L (no) | 2003-05-14 |
| CA2426517A1 (en) | 2002-03-21 |
| AU2001294563A1 (en) | 2002-03-26 |
| EP1356083A2 (en) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1298180A4 (en) | HYDROPHOBIC AND LIPOPHOBE COMPOSITION | |
| NO20022334L (no) | Ny sammensetning og anvendelse | |
| DK1339292T3 (da) | Sammensætning og fremgangsmåde | |
| ID29021A (id) | Komposisi galantamina pelepasan terkontrol | |
| DE60132732D1 (de) | Primerzusammensetzung und Verbindungsverfahren | |
| DE60020100D1 (de) | Dimerverbindungen und als inhibitoren der neuramidinase | |
| EP1248642A4 (en) | PEPTIDOMIMETIC INHIBITOR OF VEGF-D / VEGF-C / VEGF | |
| PT945132E (pt) | Composicao de ibuprofeno | |
| NO20013393D0 (no) | Brönnsementeringsfremgangsmåter og sammensetninger | |
| NO993217L (no) | Broenntetningssammensetninger og fremgangsmåter | |
| ID30590A (id) | Celana sekali pakai jenis-celana pendek | |
| CY2013011I2 (el) | Μεθοδος χορηγησης διφωσφονικων | |
| DE60231927D1 (de) | Reibungsreduzierende Zusammensetzung und zugehöriges Verfahren | |
| DK1112003T3 (da) | Ny sammensætning og anvendelse | |
| NO20006488D0 (no) | Sammensetning og anvendelse | |
| EP1423399A4 (en) | HYDROXYPYRIDONATE AND HYDROXYPYRIMIDINONE CHELATIZING AGENTS | |
| DE60106968D1 (de) | Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren | |
| FI981506L (fi) | Elastomeerikompositio ja sen valmistusmenetelmä | |
| EE200400042A (et) | 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena | |
| FI990234L (fi) | MenetelmäKIinnirullauksessa | |
| PL366012A1 (pl) | Kompozycja i sposób oznaczania glikozydazy | |
| DK1061955T3 (da) | Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf | |
| PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
| ATE418339T1 (de) | Zusammensetzung und verfahren | |
| FI20001716L (fi) | Rankajõrjestely ja siihen liittyvõt menetelmõt |